Status:
ENROLLING_BY_INVITATION
Evaluation of Genetic Signature in Endometriosis Disease by Non Invasive Sampling
Lead Sponsor:
Eurofins Genoma
Conditions:
Endometriosis
Hypofertility
Eligibility:
FEMALE
18-45 years
Brief Summary
Endometriosis is a disease that affects 10-15% of the general population and 50% of infertile women. It is characterized by the presence of endometrial tissue outside the uterine cavity. Endometriosis...
Detailed Description
Retrospective selection based on anamnestic criteria of: 50 patients with diagnosed endometriotic adnexal pathology (case, CA), 50 patients with non-endometriotic adnexal pathology (control, CO) and 5...
Eligibility Criteria
Inclusion
- Case population (CA), patients with endometriotic adnexal pathology
- Control population (CO), patients with non-endometriotic adnexal pathology
- Analytical control population (C-), patients with no gynecologic pathology, not undergoing surgery
Exclusion
- Women with ages outside the inclusion range
- Pregnant patient
- Patient with a personal history of cancer
- Patient infected with HIV
Key Trial Info
Start Date :
May 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06100471
Start Date
May 1 2023
End Date
December 31 2024
Last Update
February 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eurofins Genoma
Rome, Italy, 00138